top of page

March 2021 // News

  • Sandra Glasmacher
  • Mar 29, 2021
  • 1 min read

Updated: Dec 30, 2025

We are excited to share a scientific publication about the beneficial effect of the prototype SERI WOBE437 in a clinically relevant mouse model of Multiple Sclerosis and transient spasticity.


The article is published on ACS Pharmacology & Translational Science as the result of collaborative work between the group of Prof. J. Gertsch and Prof. B. Engelhardt at the University of Bern under the leadership of Dr. Andrea Chicca.


Find out more https://pubs.acs.org/doi/10.1021/acsptsci.0c00214



Graphic: Reynoso-Moreno et al., 2021.

Recent Posts

See All
September 2025 // News

Dr. Andrea Chicca, CEO, shares the highly promising results from Synendos Phase 1 Trials

 
 
October 2024 // News

Synendos Secures Innosuisse Funding to Advance Clinical Development of SYT-510

 
 
July 2024 // News

Synendos is excited to announce the publication of the latest article written by Andrea Chicca and Jürg Gertsch

 
 
bottom of page